Similar medications and substitutes for BEVACIZUMAB-AWWB
In short: Mvasi (BEVACIZUMAB-AWWB) belongs to the Vascular Endothelial Growth Factor Inhibitor class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Mvasi is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Mvasi in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.